Traduire
Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022
NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire
Spreading safe, cheap embolization around the world
Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice
R&D
Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.
Services
CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.
Training
Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.
Recent Posts
-
Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 - 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
- FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
- Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
- Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Dernières Publications (5/426)
- Bobot, M, Bruyat, A, Thomas, L, Fernandez, S, Brodovitch, A, Boucraut, J et al.. Blood-brain barrier permeability in CKD: link with inflammation and cognitive and mood impairment in rats. Behav Brain Res. 2025; :115693. doi: 10.1016/j.bbr.2025.115693. PubMed PMID:40513958 .
- Mecerli, S, Cazauvieilh, V, Vial, R, Colson, S, Roman, C, Bobot, M et al.. [Effectiveness of virtual reality interventions on anxiety and depressive symptoms in hemodialysis patients: A systematic review]. Nephrol Ther. 2025;21 (3):1-10. doi: 10.1684/ndt.2025.122. PubMed PMID:40495768 .
- Deux, JF, Habert, P. Cardiac MRI in Fabry disease: T1 mapping as a quantitative biomarker for treatment monitoring. Diagn Interv Imaging. 2025; :. doi: 10.1016/j.diii.2025.04.005. PubMed PMID:40280801 .
- Verger, A, Doyen, M, Heyer, S, Goehringer, F, Bruyere, A, Kaphan, E et al.. Reorganization of brain connectivity in post-COVID condition: a 18F-FDG PET study. EJNMMI Res. 2025;15 (1):28. doi: 10.1186/s13550-025-01217-7. PubMed PMID:40158051 PubMed Central PMC11954761.
- Bodin, S, Damiana, TST, Previti, S, Balasse, L, Ali, L, Rémond, E et al.. N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake. J Med Chem. 2025;68 (7):7280-7290. doi: 10.1021/acs.jmedchem.4c02844. PubMed PMID:40111113 .